I kēia mau lā, ʻo Sanxin Medical extracorporeal circulation pipeline ma o ka United States Food and Drug Administration (FDA) marketing authorization (K202796), ʻo ia ka mua o ka sanxin medical blood hoʻomaʻemaʻe moʻo huahana i loaʻa i ka FDA marketing authorization (510K)! (510K) ka mana kūʻai aku ma hope o ka ʻoihana palekana syringe, disposable sterile syringe, IV catheter a me ka medical mask. Ua lilo pū ʻo Sanxin Medical i mea hana mua o nā laina extracorporeal circulation ma Kina no ka loaʻa ʻana o ka FDA (510K) mana kūʻai, e uhi ana i nā ʻano hana lapaʻau he nui. hoʻomaʻemaʻe koko (hemodialysis, hemofiltration, hemodiafiltration, hemoperfusion, etc.).I kēia manawa, aia ma lalo o 20 mau mea hana o extracorporeal circulation line ma ka honua holoʻokoʻa i loaʻa ka ʻae kūʻai FDA.

Hoʻokumu ʻia ma 1997, ʻo Sanxin Medical kahi ʻoihana ʻenehana kiʻekiʻe o ka ʻāina i ka noiʻi, hoʻomohala, hana, kūʻai aku a me ka lawelawe ʻana i nā mea lapaʻau.Ma hope o 20 mau makahiki o ka hoʻomohala ʻana, ua ulu ʻo Sanxin Medical i mea alakaʻi alakaʻi i nā hopena hemodialysis piha i Kina.ʻO ia ka mea mua i ka ʻoihana i hala i ka ʻōnaehana hoʻokele maikaʻi ʻo CE CMD a me ka hōʻoia huahana. ʻO ka ʻae ʻia ʻana o FDA (510K) e hōʻailona ana i nā huahana hemodialysis pipeline o Sanxin Medical i ka par me ka pae papa mua o ka honua, a He hōʻike ikaika nō hoʻi i ka loaʻa ʻana o ka mākeke Kina i ka mākeke honua a me ka ʻike.Ua wehe ʻo Sanxin Medical i kahi manawa hou o ka hoʻokūkū mākeke honua.

E lawe ʻo Sanxin Medical i kēia manawa kūpono e hoʻomau i ka hoʻomohala ʻana i ke ʻano hoʻolālā o ka noiʻi kūʻokoʻa a me ka hoʻomohala ʻana a me ka hoʻomohala ʻana i ka honua holoʻokoʻa, e hoʻokau i ka misionari o ka hoʻomohala ʻana i nā lako lāʻau lapaʻau aupuni, hoʻolaha i nā huahana kiʻekiʻe i ka honua, hāʻawi i nā mea maʻi me ka palekana a kiʻekiʻe. -ʻoi aku ka maikaʻi o nā huahana a me nā lawelawe, a kōkua i ka hoʻomohala ʻana i ke kumu olakino a me ke olakino.